Boston Scientific (BSX) closed the most recent trading ... At the same time, our most recent consensus estimate is projecting a revenue of $4.56 billion, reflecting a 18.2% rise from the ...

Analysts expect the company to report earnings of $0.65 per share on revenue growth of 15.44 percent for the quarter. For the full year, Boston Scientific sees revenue growth of about 12.5 percent ...

This may suggest a higher level of investor confidence and market recognition. Revenue Growth: Boston Scientific's remarkable performance in 3M is evident. As of 31 December, 2024, the company ...